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Predictors of Poor Quality of Life after Primary 
Lower Limb Deep Venous Thrombosis:  
A Perspective from a Developing Nation
Nadeem Ahmad Siddiqui, MBBS, FCPS,1 Muhammad Asad Moosa, MBBS, FCPS,1  
Fareed Ahmad Shaikh, MBBS, FCPS,1 Noman Shahzad, MBBS, FCPS,2  
Shahid Nazir, MBBS,1 and Ziad Sophie, MD1
Objective: We aimed to determine predictors of poor long 
term quality of life, using the VEINES Quality of Life (QOL) 
questionnaire, in patients with lower limb deep venous 
thrombosis (DVT).
Material and Methods: This study included adult pa-
tients with primary lower limb DVT between January 2007 
and December 2017. Post thrombotic syndrome (PTS) was 
assessed using the Villalta score and Quality of Life (QoL) by 
the VEINES quality of life questionnaire.
Results: Our study included 125 patients, 57 (45.6%) of 
whom were males. The patient population’s median age 
was 41 years (IQR: 34–47 years). The median follow up 
was 450 days (IQR: 390–1020 days). PTS occurred in 49 
(39.2%) patients. Independent predictors of poor quality of 
life post DVT were progression to PTS, complete occlusion 
of vein, proximal (Ileofemoral) DVT, poor control of INR, 
poor compliance with compression stockings, severity of 
PTS, ileofemoral DVT and poor control of therapeutic anti-
coagulation.
Conclusion: Predictors who are independently associated 
with poor quality of life post DVT are PTS, inability to main-
tain therapeutic anticoagulation and ileofemoral DVT.
Keywords: quality of life, deep vein thrombosis, VEINES-
QOL, predictors, post thrombotic syndrome
Introduction
Deep vein thrombosis (DVT) is a long term, debilitating 
condition that usually involves the lower extremities. 
Around 460,000 in Europe and 300,000 people in North 
America are affected by DVT each year.1) DVT occurs as 
an acute condition, but its sequel can be very troublesome, 
ranging from massive venous thromboembolism to venous 
congestion in the extremity, leading to skin changes and 
ulcerations. Of these, venous thromboembolism (VTE) 
can be life threatening, with reported incidence of VTE-
associated mortality is 19%2) in literature. The natural 
course of DVT is an acute event, which is associated with 
an episode of massive limb swelling and pain. This gradu-
ally settles down in weeks to months’ time, but one third 
of the population affected by DVT do not recover com-
pletely, continuing to suffer from chronic longstanding 
complications after the event.3) A constellation of symp-
toms takes place in this one third of population, which 
include generalised limb oedema, usually not associ-
ated with pain, leg discomfort, fatigue and skin-associated 
changed (excoriation and ulcerations). This condition is 
referred to as post thrombotic syndrome (PTS) and has an 
incidence of 25–50% in a population who previously had 
DVT in their lives.4–6) PTS is manageable, to some extent, 
with conservative measures like compression stockings 
until the involvement of skin. Once ulcers develop in PTS, 
the patient’s quality of life is seriously affected because of 
obstacles to daily, routine activities and increased cost of 
treatment. Taking care of the treatment cost in our patient 
population, or any patient population, from a developing 
nation is essential as there is no concept of health insur-
ance and most patients are self-payers. There are several 
studies from Western and developed nations which report 
impaired quality of life in patients with PTS and skin 
ulceration. Different tools were used to measure quality 
of life in these studies, like Short Form Health Survey 36 
(SF 36), DVTQOL, EQ-5D and VEINES Quality of Life 
(QOL).7,8) Also, post DVT quality of life is comparable to 
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the quality of life after other serious ailments, like conges-
tive heart failure, chronic obstructive pulmonary disease 
and diabetes (DM).7) There is minimal post DVT quality 
of life data available from the developing world. As men-
tioned earlier, we assume quality of life is affected more 
seriously in this population due to low income and higher 
out-of-pocket costs for treatment. More information 
about various factors linked to poor quality of life in post 
DVT patients will help further define ways to avoid those 
factors and design strategies to improve quality of life. 
Therefore, we intended to find out the predictors of poor 
quality of life after lower limb DVT using the VEINES 
QOL questionnaire.
Materials and Methods
We conducted a retrospective cohort study in section of 
Vascular Surgery, Department of Surgery, Aga Khan Uni-
versity Hospital Karachi. This included all adult patients, 
aged 16 and above, admitted to our hospital with primary 
lower limb DVT between January 2007 and December 
2017. We excluded patients who had incomplete records, 
missing files, issues with obtaining informed consent, and 
patients having stroke, malignancy, and paraplegia. After 
identifying patients via hospital medical record systems 
and the International Classification of Disease (ICD-9) 
coding, patients were reached by phone. Patients were 
seen during free follow up, where they provided informed 
consent. Predefined questionnaire included details of de-
mographics and other clinical details which were filled in 
the clinic. Patients were specifically asked for the duration 
of post DVT compression therapy, and the threshold to 
compression compliance was taken as compression used 
for eight hours per day for at least four days per week. 
This initial detail was followed by a physical examination, 
carried out by both the principal investigator and a Vas-
cular Consultant to avoid inter-observer bias. PTS severity 
was assessed using the Villalta score, and the VEINES 
QOL questionnaire was used to assess the degree of im-
pairment in quality of life. The VEINES QOL consists of 
26 variables and includes details regarding symptoms, 
daily activity limitations, and psychological impact. These 
scores cover the disease related variable, and it also has 
good psychometric properties.
Table 1 Demographic characteristics and disease related measures
Variables Categories Median (IQR) or N (%)
Age (Years) 41 (34–47)
Sex Male 57 (45.6%)
Follow up duration (Days) 450 (390–1020)
Location Ileo-femoral 26 (20.8%)
Other 99 (79.2%)
Extent of obstruction Complete 48 (38.4%)
Partial 77 (61.6%)
Obesity BMI ≥30 62 (49.6%)
Recent surgery 51 (40.8%)
Family history of DVT 30 (24%)
Smoking Current smoker 26 (20.8%)
Past smoker 9 (7.2%)
Never smoker 90 (72%)
Compression therapy 122 (97.6)
Use of compression therapy as recommended > 4 times per week and >8 h/week 27 (21.6%)
Use of compression therapy Less than 8 h 89 (71.2%)
8–16 h 36 (28.8%)
Compliance of compression therapy Less than 4 times/week 50 (40%)
More than 4 times/week 60 (48%)
Hypercoagulable state 64 (51.2%)
Range of INR Stable 80 (64%)
Not stable 45 (36%)





IQR: interquartile range; BMI: body mass index; DVT: deep venous thrombosis; INR: international normalised ratio
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Data was analysed using the Statistical Package for 
Social Science (SPSS), v.20. Frequency tables were used to 
describe the patients’ demographics and clinical details. 
Frequencies and percentages were used for qualitative 
variables, and medians with interquartile ranges (IQR) 
were used for quantitative variables due to non-normal 
distribution. Univariate analysis was conducted to assess 
the association of different variables with poor quality of 
life. The Mann–Whitney U test was applied to assess qual-
itative variable association with quality of life. Spearman’s 
correlation coefficients were used to assess the association 
of quantitative variable with quality of life. Multiple lin-
ear regression analysis was done to look for independent 
predictors for impaired quality of life. A P value of less 
than 0.05 was considered significant.
Results
Of the 569 patients who presented to our hospital with 
diagnoses of DVT, 258 were enrolled in the study accord-
ing to the inclusion criteria. We were able to reach 200 
patients through telephone; of these 200, only 125 visited 
the clinic and participated in the study. The patients’ medi-
an age was 41 years (IQR: 34–47 years); 57(45.6%) of the 
participants were males, and the median follow up time 
period was 450 days (IQR: 390–1020 days). Most DVT 
cases (79, or 63.2%) involved the left lower limb. Only 
three patients (2.4%) had bilateral lower limb DVT, 26 
(20.8%) patients presented with proximal (ileofemoral) 
DVT, and 48 (38.4%) patients experienced complete vein 
occlusion. PTS occurred in 49 patients (39.2%). Table 1 
provides further demographic data. These patients had a 
median VEINES QOL score of 51 (IQR: 39–58).
A univariate analysis revealed the variable that had the 
worst association with the post DVT quality of life was 
proximal DVT location, complete vein obstruction on 
ultrasound, presence of PTS, obesity, inappropriate anti-
coagulation management on follow up, and inappropriate 
use of compression stockings (both duration and compli-
ance), as shown in Tables 2 and 3, respectively. Forward, 
stepwise, multivariate linear regression analysis was done 
Table 2 Relationship of various binomial categorical predictor variables with Quality of Life after DVT using the Mann–Whitney U test
Variables Categories Means +/− SDs of VEINES-QOL score P Values
Gender Male 55 (40–58) 0.188
Female 49 (39–57)
Obesity Yes 40 (39–49) 0.018
No 55 (42–58)
Recent surgery Yes 50 (44–56) 0.627
No 55 (39–58)
Location of DVT Ileofemoral DVT 33 (29–46) <0.001
Others 55 (44–58)
Obstruction on U/S Complete 45 (32.5–57) 0.025
Partial 53 (44–58)
IVC filter placed Yes 54.5 (37.5–57) 0.848
No 50 (40–58)
PTS Yes 42 (34–47) <0.001
No 57 (50–58)
PE on CTscan Yes 46.5 (34.5–58.5) 0.832
No 49 (44–57)
Range of INR Stable 55.5 (44.5–58) <0.001
Not stable 44 (29–53)
Hypercoaguble state Present 47.5 (39–57.5) 0.174
Absent 55 (40–58)
Duration of compression Less than 8 h/day 48 (39–56) <0.001
8–16 h/day 57.5 (50–59)
Compliance of compression Less than 4 times/week 46.5 (40–55) <0.001
More than 4 times/week 56 (42.5–59)
DVT: deep venous thrombosis; SD: standard deviation; U/S: ultrasound; IVC: inferior vena cava; PTS: post thrombotic syndrome; PE: 
pulmonary embolism; CT: computed tomography; INR: international normalised ratio 
Table 3 Correlation of various continuous predictors with 
Quality of Life after DVT using Spearman’s 
Correlation
Variable Spearman’s Rho P value
Age 0.212 0.018
Villalta score −0.617 <0.001
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to determine independent predictors of poor quality of 
life. The P value, at the univariate level of less than 0.1, 
was taken as a cut off value for the variable to be included 
in multivariate analysis. So variables like obesity, DVT lo-
cation, extent of obstruction on ultrasound, compression 
therapy duration, compliance with compression therapy, 
age, time of follow up, range of INR, and Villalta score 
were included in multivariate analysis. Ileofemoral DVT, 
unstable INR range on follow up, and the Villalta score 
turned out to be the only independent predictors of poor 
quality of life. The multivariable regression analysis re-
sults are shown in Table 4.
Figure 1 illustrates the relationship of the Villalta score 
with quality of life. It shows an inverse relationship of 
VEINES quality of life score with Villalta score. Increased 
severity of post-thrombotic syndrome is related to poorer 
quality of life.
Discussion
This study shows the association of poor quality of life 
scores in patients with DVT. We found that PTS is a com-
monly occurring phenomenon after a DVT episode, which 
sometimes presents as a disabling complication of a DVT. 
The median age of our population was 41 years; the av-
erage life expectancy in our country, as of 2016, is 66.8 
years,9) which shows the significance of this condition. In 
our study, the Villalta score showed that PTS severity is an 
independent predictor of worse quality of life. In our study 
sample, PTS was seen in 40% of patients which indicates 
the disease’s hidden burden. This finding is also compara-
ble to other reports in the literature which determined the 
predictors of poor quality of life. A report by Roberts LN 
et al. identified similar findings of PTS as an independent 
predictor of poor quality of life.10) Another report claims 
that worsening PTS severity is directly proportional to the 
worse quality of life post DVT.11) Measures to avoid this 
PTS severity are also highlighted in a few studies; using 
elastic compression stockings is and good compliance can 
prevent PTS development/progression.12,13)
Our study also associated proximal (Ileofemoral) DVT 
with poor quality of life, which is comparable to previous 
studies reported in the literature. A review article by Khan 
SR et al, also emphasised the association of proximal (Il-
eofemoral) DVT with greater PTS occurrence.14) Although 
the exact mechanism of this association is not clear, the 
Table 4 Multivariable linear regression analysis. Dependent variable being VEINES QOL score. Only predictor variables that remained 
significant are shown.
Model
Unstandardized coefficients Standardized coefficients
T-statistic P value Odds ratio
B Std. error Beta coefficient
(Constant) 47.284 4.152 11.388 <0.001
Villalta score −.796 .125 −.445 −6.379 <0.001 0.474
Range of INR −5.754 1.474 −.261 −3.903 <0.001 0.004
Ileofemoral DVT 7.077 1.802 .271 3.927 <0.001 0.001
QOL: quality of life; INR: international normalised ratio; DVT: deep venous thrombosis
Fig. 1  Scatter plot of Quality of Life score over the Villalta score with fitted values and 95% 
confidence interval limits.
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authors state that, in proximal (Ileofemoral) DVT, the 
obstruction of the extremity veins are proximal to point 
where the profunda femoral veins enters. As a result, there 
is a decrease in the formation of collaterals and a higher 
chance of PTS than the distal (popliteal) DVT concomi-
tantly.14) Another highlight of our study is the association 
of poor control of therapeutic range of INR and worse 
quality of life, which emphasises the importance of moni-
toring anticoagulation closely during DVT treatment. This 
was also emphasised in a report from Dongen CJ et al., 
which stated that maintaining appropriate therapeutic 
anticoagulation further helps develop PTS.15) To make our 
findings more objective, the post DVT QOL measurement 
was confirmed by disease-specific tools, such as the VEI-
INES QOL questionnaire. Various generic and disease-
specific tools are available in the literature, but studies 
have proven that a disease-specific tool like VEINES QOL 
correlates better than generic tools like SF-36.16)
A major limitation of our study was its retrospective 
nature with small sample size. No baseline or pre DVT 
quality of life score was available for comparison, which 
made seeing the actual difference in quality of life difficult. 
Despite these limitations, our study’s greatest strength is 
the first of its kind to be reported from this region of the 
world, addressing post DVT quality of life and an effort 
to establish prognostic risk factors for poor quality of life. 
Another strength of the study is post DVT patient follow 
up; we made sure that each participant was followed for 
at least one year. We managed all of our patients with 
conservative measures (anticoagulation and compression) 
and not by thrombolysis; this further highlights the facts 
about PTS in a patient population which was managed 
conservatively. This study’s results can be used further in 
comparing quality of life predictors in conservative versus 
thrombolysis DVT management. We would certainly have 
difficulty in conducting such a comparison because of cost 
issues in thrombolysis, as patients are self-payers and opt 
for conservative management. Limitations of our study 
includes retrospective review, loss to follow up and people 
unwilling to participate in the study.
Conclusion
Predictors that are independently associated with poor 
quality of life post DVT are PTS, inability to maintain 
therapeutic anticoagulation and ileofemoral DVT. This 
can be avoided in proper counselling of patients to comply 
with measures like compression stockings to avoid devel-
oping PTS and also educating on maintaining therapeutic 
anticoagulation.
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